Search research articles
Contact Us
Filters
Showing results (241-250 of 247) with videos related to
Page
of 25
Sort By:
You have reached the last page of results.
This site can display upto 247 results.
Annals of Surgery
|
February 7, 2022
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers
Kristy K Broman, Tasha M Hughes, Brooke C Bredbeck, et al.
Cancer
|
October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
Joanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
Annals of Surgical Oncology
|
January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Cancer
|
April 7, 2021
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)
Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, et al.
Cancers
|
January 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus
Juan Alban, R Christopher Bowen, David A Reichstein, et al.
JAMA Surgery
|
August 3, 2022
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial
, Jessica S Crystal, John F Thompson, et al.
The New England Journal of Medicine
|
June 8, 2017
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B Faries, John F Thompson, Alistair J Cochran, et al.
Page
of 25
Search research articles
Search
Showing results (241-250 of 247) with videos related to
Sort By:
Page
of 25
You have reached the last page of results.
This site can display upto 247 results.
Annals of Surgery
|
February 7, 2022
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers
Kristy K Broman, Tasha M Hughes, Brooke C Bredbeck, et al.
Cancer
|
October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
Joanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
Annals of Surgical Oncology
|
January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Cancer
|
April 7, 2021
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)
Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, et al.
Cancers
|
January 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus
Juan Alban, R Christopher Bowen, David A Reichstein, et al.
JAMA Surgery
|
August 3, 2022
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial
, Jessica S Crystal, John F Thompson, et al.
The New England Journal of Medicine
|
June 8, 2017
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B Faries, John F Thompson, Alistair J Cochran, et al.
Page
of 25